Susquehanna International Securities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Susquehanna International Securities’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,000	Closed	-$2.15M	–	82
2020 Q1	$2.15M	Buy	+11,000	New	+$2.37M	0.87%	27
2019 Q4	–	Sell	-5,500	Closed	-$840K	–	88
2019 Q3	$840K	Hold	5,500	–	–	0.18%	67
2019 Q2	$709K	Sell	5,500 -10,500	-66%	-$1.25M	0.23%	63
2019 Q1	$1.88M	Buy	16,000 +9,500	+146%	+$958K	0.46%	43
2018 Q4	$596K	Buy	+6,500	New	+$659K	0.47%	31

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Susquehanna International Securities's LKFT Position: Q2 2021 in Review

Susquehanna International Securities sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 21,700 shares — an estimated $1.67M sold.

Susquehanna International Securities first reported a position in LKFT in Q1 2019 and held it in 7 quarters. The position peaked at $2.67M in Q4 2019. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Susquehanna International Securities reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Susquehanna International Securities sold 21,700 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $1.67M.
Susquehanna International Securities first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 7 quarters.
Susquehanna International Securities's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.67M in Q4 2019.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Susquehanna International Securities's 13F filing for Q2 2021, filed 11 Aug 2021.